The lack of clarity surrounding the definition of an academic cancer center has real-world implications for manufacturers and patients. https://ow.ly/ttH250TaPeJ Matthew Cunningham writes about the challenges in developing a consensus definition and provides recommendations to navigate the complexity.
The Dedham Group
Business Consulting and Services
New York, NY 17,217 followers
Management and Strategic Consulting Services
About us
The Dedham Group is the premier US oncology & specialty therapeutics strategy consulting firm that combines deep clinical expertise in specialty disease areas, commercial & market access expertise and proprietary analytics to provide highly differentiated recommendations & strategic support to our clients in the pharmaceutical and biotech industry. Our work focuses on being highly data-driven and developing highly custom and integrated strategies in exciting areas of clinical innovation which span oncology, cell & gene therapy, immunology, neurology, rare diseases and precision medicine. We are deeply embedded with our clients which span senior leaders across sales & marketing, market access, distribution & patient services, pricing & contracting and channel strategy across marquee brands on the cutting edge of clinical innovation from many of the most admired companies. Our team is comprised of highly talented entrepreneurial, collaborative and creative leaders that are focused on insights development, storytelling and creating custom strategies & products for our strategic clients, maintaining the high quality & deep specialization expectations of a boutique firm. Our organization prides itself on being a merit-driven, team-based, high-performance culture where our people care greatly about their clients’ careers, the impact of their work and the overall well-being of their colleagues.
- Website
-
http://www.dedhamgroup.com
External link for The Dedham Group
- Industry
- Business Consulting and Services
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2010
- Specialties
- Consulting, Healthcare, and Research
Locations
-
Primary
1 Penn Plaza
Suite 2505
New York, NY 10119, US
Employees at The Dedham Group
Updates
-
Elevate your digital health strategy with The Dedham Group. https://ow.ly/2e0S50T4xnU Our expert team delivers unparalleled insights and strategies to help you stay ahead in the rapidly evolving healthcare landscape. Partner with us to make informed decisions and drive digital health innovation forward.
-
Final Chance to Register! Don’t miss out—Join The Dedham Group and AssistRx on August 20, 2024, at 1 PM EST for an essential, interactive webinar on the Inflation Reduction Act’s impact on patient support programs. https://ow.ly/RXwx50SZowp Learn how to address patient and healthcare provider education and support needs effectively. Register Now!
-
Mark your calendars! Join The Dedham Group and AssistRx on August 20, 2024, at 1 PM EST for an engaging and interactive webinar on the Inflation Reduction Act’s impact on patient support programs. https://ow.ly/rJa950SYC93 Discover strategies to enhance your programs and patient & provider education. Secure your spot now—register today!
-
How can we ensure essential treatments reach those in need in a world of growing payer restrictions? https://ow.ly/nS5q50SV0mW The Dedham Group, in collaboration with MMIT (Managed Markets Insight & Technology), surveyed 300+ pharma and biotech leaders to explore current and future patient access challenges. Discover the insights shaping the future of patient access with The State of Patient Access – Inaugural Report by clicking the link in this post.
-
Discover how the FDA’s new guidance on Prescription Drug Use-Related Software (PDURS) can drive brand differentiation and commercial success in the pharmaceutical industry. https://ow.ly/Ic8v50SPo0T In our new thought leadership article, Manuel Jurado from The Dedham Group and Austin Speier and Steven L. from Click Therapeutics, Inc. explore the opportunities this guidance presents. Click the link in this post for the insights.
-
Discover the power of PULSE Analytics' Payer Quality of Access Tool. https://ow.ly/cseN50Sy1M9 Evaluate coverage restrictions, regional targets, and competitive access to optimize your strategic planning. Ready to unlock actionable insights? Connect with us today!
-
Pharma companies can help patients access biomarker testing by providing resources on patient identification, available vendors, proof of eligibility, and ordering instructions. The Dedham Group’s Jennifer (Goldenberg) Klarer, M.Sc.Eng. and Hannah Baxter with MMIT (Managed Markets Insight & Technology)'s Carolyn Zele share tips for oncology manufacturers in Drug Channels: https://ow.ly/XBmY50RG2fe. #Pharma #PharmaManufacturers #MarketAccess #Oncology
-
Few drugs have gripped the American public, like GLP-1 weight-loss medications. The strong sales of GLP-1 drugs raise questions about how insulin pricing crackdowns will affect pipeline strategies and how biopharma manufacturers will address supply issues to support diabetes patients. In a recent BioSpace BioSpace article, The Dedham Group’s Manuel Jurado provides commentary on the connection between the GLP-1 and the insulin market. Check out the full article: https://ow.ly/tg7E50RRF6Z #GLP1 #Insulin #Biopharma #PharmaceuticalCompanies
As Sales of Weight Loss Drugs Skyrocket, the Insulin Market Falters | BioSpace
biospace.com